Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

130.05
+2.031.58%
Pre-market: 130.050.00000.00%04:00 EDT
Volume:125.33K
Turnover:16.29M
Market Cap:541.00M
PE:6.74
High:130.28
Open:128.66
Low:128.45
Close:128.02
52wk High:131.68
52wk Low:90.01
Shares:4.16M
Float Shares:4.16M
Volume Ratio:3.81
T/O Rate:3.01%
Dividend:1.06
Dividend Rate:0.82%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.62
PE(LYR):5.98

Loading ...

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS
·
Aug 27

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
Aug 27

Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial

TIPRANKS
·
Aug 27

Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval

TIPRANKS
·
Aug 26

Eli Lilly and Co Stock (LLY) Opened Down by 3.57% on Aug 26: Facts Behind the Movement

TradingKey
·
Aug 26

US Companies Face Rise in Cyber Attacks

Reuters
·
Aug 26

Eli Lilly Study Shows Lower Healthcare Costs With Zepbound in Older Adults

MT Newswires Live
·
Aug 26

Gubra Earns USD 50 Million Milestone as AbbVie Starts Phase 2 Trial of Obesity Drug ABBV-295

Reuters
·
Aug 26

Zepbound Linked to Lower Healthcare Costs in Adults over Age 55 with Obesity According to a Real-World Study

THOMSON REUTERS
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26